Clinical Trial Update: Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 trial evaluating the safety of ciliary neurotrophic factor implants in the eye for retinitis pigmentosa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• Ciliary Neurotrophic Factor Implant (ciliary neurotrophic factor implant)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Retinitis Pigmentosa | Phase 1 | Status: COMPLETED